Dr. Ronald Aung-Din has practiced General Neurology and Neuropsychiatry for over 25 years. He is board-certified by the American Board of Psychiatry and Neurology and is a member of the American Academy of Neurology. His extensive educational resume and includes multiple degrees in the health and science fields as well as fellowships and residencies with internationally-acclaimed hospitals and schools of medicine.
Dr. Aung-Din has participated in over 60 pharmaceutical industry-sponsored clinical trials, helping bring to market current drugs for Multiple Sclerosis (MS), epilepsy, post-herpetic neuralgia, and other neurologic conditions. He currently serves as Principal Investigator in a number of ongoing drug research studies and is the Founder and Research Director of the Tourette’s Research Institute.
Dr. Aung-Din is active in treating varied neurological and psychiatric conditions using delivery of Central Nervous System-active drugs with Direct Effects™ topical delivery, a unique technology he developed. To date, seven (7) patents for Direct Effects™ have been granted in the United States, Europe, and Australia with others filed and pending.
ISODERM™ with Direct Effects™ technology offers the most effective and bioavailable form of CBD on the market today. With a truly innovative delivery method, Direct Effects™ allows neuroactive drugs to directly affect nerve tissue, bypassing traditional means of absorption.
Direct Effects™ utilizes advanced BONATH™ (Back of the Neck at the Hairline) delivery and works rapidly for headaches, body and joint pain, and nervous system disorders.
- Faster-acting than traditional delivery methods
- Vastly reduces side effects
- Enhances overall efficacy
Apply 1-3 pumps to the back of the neck at the hairline once or twice daily or as recommended by a physician.
Innovations in Medicine